The Europe Collagen Market is projected to grow significantly, reaching an estimated US$ 2,139.0 million by 2031, up from US$ 1,570.2 million in 2024. This growth reflects a compound annual growth rate (CAGR) of 4.5% from 2025 to 2031, indicating a robust demand for collagen products across various sectors.
For instance, in July 2024, Evonik introduced VECOLLAN, a next-generation recombinant collagen produced through a controlled, animal-free microbial fermentation process. This product offers exceptional biocompatibility and consistent quality, which are crucial for advanced biomedical applications like wound healing, tissue regeneration, and 3D bioprinting. VECOLLAN is designed for various forms and cross-linking options, significantly broadening the functional potential of collagen beyond traditional uses.
Similarly, CollPlant Biotechnologies has developed a plant-based recombinant human collagen (rhCollagen) using genetically engineered tobacco plants. This innovative platform allows for scalable, safe, and sustainable collagen production for applications in medical aesthetics, regenerative medicine, and orthobiologics. CollPlant's collaborations with industry leaders to create 3D bioprinted implants and aesthetic products highlight the commercial and therapeutic viability of these advanced collagen forms.
Consumer-facing innovations are also emerging. For example, Realize Collagen, in partnership with Wellnex, utilizes advanced hydrolysis techniques to produce collagen peptides with enhanced absorption and bioavailability. These innovations target areas such as skin elasticity, joint health, and muscle recovery, improving consumer outcomes and satisfaction. Such technological breakthroughs address previous challenges like immunogenicity, inconsistent quality, and ethical concerns, paving the way for new collagen applications. By enhancing scalability, safety, and performance, these innovations are driving the adoption of collagen across diverse sectors. As research and development continue to expand the possibilities of collagen, the global market is set for sustained growth fueled by these transformative advancements.
Executive Summary and Market Analysis
Europe stands as one of the largest markets for baked goods globally, with the UK being a major contributor to this sector. According to the Annual Business Survey, the bakery industry in the UK was valued at approximately US$ 5.8 billion in 2022, accounting for around 13% of the total food and beverage manufacturing gross value added. Among bakery products, bread is the fastest-growing category, with 99.8% of British households purchasing it and around 11 million loaves sold daily. Hydrolyzed collagen and gelatin are increasingly utilized in baked goods to enhance baking properties and potentially extend shelf life by affecting the staling process of bread. The addition of collagen to dough improves its crumb hardness, texture, and overall structure, making it a valuable ingredient in the baking industry.Strategic Insights
Market Segmentation Analysis
The Europe Collagen Market can be segmented based on product type, source, and application:
- By Product Type: The market is divided into Gelatin, Hydrolyzed Collagen, Native Collagen, Synthetic Collagen, and Others. In 2024, the Gelatin segment was the market leader.
- By Source: The collagen market is categorized into Bovine, Porcine, Poultry, Marine, and Others, with the Bovine segment dominating in 2024.
- By Application: The applications of collagen include Food and Beverages, Pharmaceuticals and Nutraceuticals, Personal Care and Cosmetics, Animal Nutrition, Healthcare, and Others. The Pharmaceuticals and Nutraceuticals segment was the largest in 2024.
Market Outlook
Technological advancements in collagen extraction and processing have revolutionized the efficiency, purity, and application potential of collagen-based products. Innovations such as recombinant technology, precision fermentation, and optimized enzymatic hydrolysis have led to the development of highly bioavailable, customizable, and sustainable collagen solutions suitable for various industries, including medical, nutraceuticals, and cosmetics.For instance, in July 2024, Evonik introduced VECOLLAN, a next-generation recombinant collagen produced through a controlled, animal-free microbial fermentation process. This product offers exceptional biocompatibility and consistent quality, which are crucial for advanced biomedical applications like wound healing, tissue regeneration, and 3D bioprinting. VECOLLAN is designed for various forms and cross-linking options, significantly broadening the functional potential of collagen beyond traditional uses.
Similarly, CollPlant Biotechnologies has developed a plant-based recombinant human collagen (rhCollagen) using genetically engineered tobacco plants. This innovative platform allows for scalable, safe, and sustainable collagen production for applications in medical aesthetics, regenerative medicine, and orthobiologics. CollPlant's collaborations with industry leaders to create 3D bioprinted implants and aesthetic products highlight the commercial and therapeutic viability of these advanced collagen forms.
Consumer-facing innovations are also emerging. For example, Realize Collagen, in partnership with Wellnex, utilizes advanced hydrolysis techniques to produce collagen peptides with enhanced absorption and bioavailability. These innovations target areas such as skin elasticity, joint health, and muscle recovery, improving consumer outcomes and satisfaction. Such technological breakthroughs address previous challenges like immunogenicity, inconsistent quality, and ethical concerns, paving the way for new collagen applications. By enhancing scalability, safety, and performance, these innovations are driving the adoption of collagen across diverse sectors. As research and development continue to expand the possibilities of collagen, the global market is set for sustained growth fueled by these transformative advancements.
Country Insights
The Europe Collagen Market is also analyzed by country, with key segments including Germany, France, Italy, Spain, the United Kingdom, and the Rest of Europe. In 2024, the Rest of Europe held the largest market share. Countries such as Switzerland, Belgium, Cyprus, Greece, Hungary, Ireland, Russia, Slovakia, and Denmark are significant players in the Rest of Europe collagen market. The rising demand for baked goods, including bread, pastries, and cakes, along with the expanding bakery industry in these countries, is driving the need for collagen as an ingredient. Additionally, the increasing domestic production of animal feed due to a growing livestock population in countries like Switzerland further supports market growth in the region.Company Profiles
Key players in the Europe Collagen Market include Darling Ingredients Inc, GELITA AG, Holista CollTech Ltd, Weishardt Holding SA, Tessenderlo Group NV, Titan Biotech Ltd, Viscofan SA, ConnOils LLC, Lapi Gelatine SpA, Nippi Inc, Nitta Gelatin Inc, Ewald-Gelatine GmbH, CNABIOTECH Co Ltd, DCP Ingredients (DCP BV), and Foodmate Co., Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their product offerings and increase market share.Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Collagen Market Landscape
5. Europe Collagen Market - Key Market Dynamics
6. Collagen Market - Europe Market Analysis
7. Europe Collagen Market Volume and Revenue Analysis - by Product Type
8. Europe Collagen Market Volume and Revenue Analysis - by Source
9. Europe Collagen Market Volume and Revenue Analysis - by Application
10. Europe Collagen Market - Country Analysis
11 Competitive Landscape
12 Industry Landscape
13 COMPANY PROFILES
14. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Europe Collagen MarketDarling Ingredients Inc
GELITA AG
Holista CollTech Ltd
Weishardt Holding SA
Tessenderlo Group NV
Titan Biotech Ltd
Viscofan SA
ConnOils LLC
Lapi Gelatine SpA
Nippi Inc
Nitta Gelatin Inc
Ewald-Gelatine GmbH
CNABIOTECH Co Ltd
DCP Ingredients (DCP BV)
Foodmate Co Ltd
